Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Contactin-1 is a glycosylphosphatidylinositol (GPI)-anchored cell adhesion protein in the immunoglobulin superfamily, encoded by the gene CNTN1[4]. It plays a critical role in the development and maintenance of the nervous system, organizing axon connections, supporting formation and maintenance of myelin sheaths, and mediating neuron-glia communication[5][1][3]. Contactin-1 forms a key adhesion complex with neurofascin 155 and Caspr, necessary for establishing paranodal axoglial junctions at nodes of Ranvier, thus regulating saltatory nerve conduction in myelinated nerves[3][5]. Dysfunction or deficiency of contactin-1 leads to disrupted myelination and neurological disorders, highlighting its major role in both central and peripheral nervous system health[5][4][3].
Modulation of paranodal axoglial junctions; Regulation of nerve impulse conduction (via myelination); Influence on axon-glia signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Contactin-1 (CNTN1).